Aprogen pharmaceuticals,Inc. (KOSE:A003060) agreed to acquire Aprogen Biologics Inc. from Aprogen, Inc. on October 4, 2022. The deal is subject to Aprogen pharmaceuticals,Inc. (KOSE:A003060) board approval. As of October 4, 2022 Aprogen pharmaceuticals,Inc. (KOSE:A003060) board approved the deal.

Aprogen pharmaceuticals,Inc. (KOSE:A003060) completed the acquisition of Aprogen Biologics Inc. from Aprogen, Inc. in December, 2022.